A phase I, single‐center, open‐label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [<scp><sup>14</sup>C</scp>] encorafenib in healthy male subjects
Pharmacology research & perspectives